Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

Delayed Quote. Delayed London Stock Exchange - 04/24 05:57:01 am
1655.68 GBp   +0.80%
56m ago Novartis sales miss forecast as readies overhaul
1h ago Novartis announces portfolio transformation, focusing company on leading..
1h agoDJNovartis 1Q Profit Rises About 23%
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

GlaxoSmithKline plc : Transaction in Own Shares

12/10/2013 | 04:27pm US/Eastern
Recommend:
0

GlaxoSmithKline plc (the Company) announces that in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 1 May 2013 it purchased 692,000 of its Ordinary Shares of 25 pence each (Shares) on 10 December 2013.

The highest price paid per Share was 1597.50 pence per Share.

The lowest price paid per Share was 1582.00 pence per Share.

The Company intends to hold these Shares in Treasury.

The Company holds 515,018,909 of its Shares in Treasury, representing 9.59% of the total issued share capital of the Company.

Including Shares which have been purchased but not yet settled, the Company holds 516,022,909 of its Shares in Treasury, representing 10.62% of the total voting rights in the Company.

The Company has 4,856,834,967 Shares in issue (excluding Shares held in Treasury). This number represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

This announcement does not constitute, or form part of, an offer or any solicitation of an offer to purchase or subscribe for securities in any jurisdiction and is in conformity with the Financial Conduct Authority's Disclosure and Transparency Rules.


This information is provided by RNS
The company news service from the London Stock Exchange
ENDPOSLLFLDFSLILIV
distributed by
Recommend :
0
React to this article
Latest news on GLAXOSMITHKLINE PLC
56m ago Novartis sales miss forecast as readies overhaul
1h ago Novartis announces portfolio transformation, focusing company on leading busi..
1h agoDJNovartis 1Q Profit Rises About 23%
3h agoDJNovartis 1st Quarter Profit Rises About 23%
4h ago EXCLUSIVE : Marubeni says Chinese authorities detain three staff at grain unit
5h agoDJNovartis First-Quarter Profit Rises About 23% -- Update
1d ago Drug deals|lift shares
1d ago GLAXOSMITHKLINE : New Hydrogen Data Have Been Reported by Researchers at GlaxoSm..
1d ago GENMAB A/S : GSK and Genmab receive FDA approval for Arzerra® ofatumumab as firs..
1d ago Novartis-GSK asset swap offers template for pharma and beyond
Advertisement
Chart
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Income Statement Evolution
GlaxoSmithKline plc : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF